CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
Oct. 17, 2018—Quest Diagnostics announced it has acquired PhenoPath, a national provider of specialized anatomic pathology and related services.
Based in Seattle, PhenoPath provides AP, molecular oncology, and other services that complement and extend those of the company’s advanced diagnostics portfolio of services such as genetic sequencing and genomic tumor analysis.
Pages: 1 2